388 related articles for article (PubMed ID: 30056124)
1. Abnormalities in behaviour, histology and prefrontal cortical gene expression profiles relevant to schizophrenia in embryonic day 17 MAM-Exposed C57BL/6 mice.
Huo C; Liu X; Zhao J; Zhao T; Huang H; Ye H
Neuropharmacology; 2018 Sep; 140():287-301. PubMed ID: 30056124
[TBL] [Abstract][Full Text] [Related]
2. Development of the MAM model of schizophrenia in mice: Sex similarities and differences of hippocampal and prefrontal cortical function.
Chalkiadaki K; Velli A; Kyriazidis E; Stavroulaki V; Vouvoutsis V; Chatzaki E; Aivaliotis M; Sidiropoulou K
Neuropharmacology; 2019 Jan; 144():193-207. PubMed ID: 30366002
[TBL] [Abstract][Full Text] [Related]
3. Decrease in parvalbumin-expressing neurons in the hippocampus and increased phencyclidine-induced locomotor activity in the rat methylazoxymethanol (MAM) model of schizophrenia.
Penschuck S; Flagstad P; Didriksen M; Leist M; Michael-Titus AT
Eur J Neurosci; 2006 Jan; 23(1):279-84. PubMed ID: 16420437
[TBL] [Abstract][Full Text] [Related]
4. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.
Moore H; Jentsch JD; Ghajarnia M; Geyer MA; Grace AA
Biol Psychiatry; 2006 Aug; 60(3):253-64. PubMed ID: 16581031
[TBL] [Abstract][Full Text] [Related]
5. Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice.
Takahashi K; Nakagawasai O; Sakuma W; Nemoto W; Odaira T; Lin JR; Onogi H; Srivastava LK; Tan-No K
Neuropharmacology; 2019 May; 150():1-14. PubMed ID: 30831160
[TBL] [Abstract][Full Text] [Related]
6. Adolescent Social Isolation Affects Schizophrenia-Like Behavior in the MAM-E17 Model of Schizophrenia.
Bator E; Latusz J; Głowacka U; Radaszkiewicz A; Mudlaff K; Maćkowiak M
Neurotox Res; 2018 Aug; 34(2):305-323. PubMed ID: 29536265
[TBL] [Abstract][Full Text] [Related]
7. Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol.
Le Pen G; Jay TM; Krebs MO
J Psychopharmacol; 2011 Jun; 25(6):822-35. PubMed ID: 21088043
[TBL] [Abstract][Full Text] [Related]
8. The prenatal methylazoxymethanol acetate treatment: a neurodevelopmental animal model for schizophrenia?
Jongen-Rêlo AL; Leng A; Lüber M; Pothuizen HH; Weber L; Feldon J
Behav Brain Res; 2004 Mar; 149(2):159-81. PubMed ID: 15129780
[TBL] [Abstract][Full Text] [Related]
9. Peri-pubertal maturation after developmental disturbance: a model for psychosis onset in the rat.
Le Pen G; Gourevitch R; Hazane F; Hoareau C; Jay TM; Krebs MO
Neuroscience; 2006 Dec; 143(2):395-405. PubMed ID: 16973297
[TBL] [Abstract][Full Text] [Related]
10. The MAM-E17 schizophrenia rat model: Comprehensive behavioral analysis of pre-pubertal, pubertal and adult rats.
Kállai V; Tóth A; Gálosi R; Péczely L; Ollmann T; Petykó Z; László K; Kállai J; Szabó I; Karádi Z; Lénárd L
Behav Brain Res; 2017 Aug; 332():75-83. PubMed ID: 28577920
[TBL] [Abstract][Full Text] [Related]
11. Behavioral perturbations after prenatal neurogenesis disturbance in female rat.
Hazane F; Krebs MO; Jay TM; Le Pen G
Neurotox Res; 2009 May; 15(4):311-20. PubMed ID: 19384565
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of BET Proteins during Adolescence Affects Prefrontal Cortical Development: Relevance to Schizophrenia.
Bilecki W; Wawrzczak-Bargieła A; Majcher-Maślanka I; Chmelova M; Maćkowiak M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445411
[TBL] [Abstract][Full Text] [Related]
13. Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies.
Potasiewicz A; Holuj M; Litwa E; Gzielo K; Socha L; Popik P; Nikiforuk A
Neuropharmacology; 2020 Jun; 170():108040. PubMed ID: 32165218
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia.
Gulchina Y; Xu SJ; Snyder MA; Elefant F; Gao WJ
J Neurochem; 2017 Nov; 143(3):320-333. PubMed ID: 28628228
[TBL] [Abstract][Full Text] [Related]
15. Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17.
Léna I; Chessel A; Le Pen G; Krebs MO; Garcia R
Psychopharmacology (Berl); 2007 Jun; 192(3):373-83. PubMed ID: 17279373
[TBL] [Abstract][Full Text] [Related]
16. Adolescent environmental enrichment prevents the emergence of schizophrenia-like abnormalities in a neurodevelopmental model of schizophrenia.
Bator E; Latusz J; Wędzony K; Maćkowiak M
Eur Neuropsychopharmacol; 2018 Jan; 28(1):97-108. PubMed ID: 29174863
[TBL] [Abstract][Full Text] [Related]
17. Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult.
O'Reilly KC; Perica MI; Fenton AA
Neurobiol Learn Mem; 2016 Oct; 134 Pt B(Pt B):294-303. PubMed ID: 27485950
[TBL] [Abstract][Full Text] [Related]
18. Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia.
Stark T; Ruda-Kucerova J; Iannotti FA; D'Addario C; Di Marco R; Pekarik V; Drazanova E; Piscitelli F; Bari M; Babinska Z; Giurdanella G; Di Bartolomeo M; Salomone S; Sulcova A; Maccarrone M; Wotjak CT; Starcuk Z; Drago F; Mechoulam R; Di Marzo V; Micale V
Neuropharmacology; 2019 Mar; 146():212-221. PubMed ID: 30496751
[TBL] [Abstract][Full Text] [Related]
19. Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia.
Featherstone RE; Rizos Z; Nobrega JN; Kapur S; Fletcher PJ
Neuropsychopharmacology; 2007 Feb; 32(2):483-92. PubMed ID: 17035930
[TBL] [Abstract][Full Text] [Related]
20. Prenatal LPS-exposure--a neurodevelopmental rat model of schizophrenia--differentially affects cognitive functions, myelination and parvalbumin expression in male and female offspring.
Wischhof L; Irrsack E; Osorio C; Koch M
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():17-30. PubMed ID: 25455585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
